InterveXion Therapeutics, LLC
5 clinical trials · Sponsor
◉ Watch InterveXion Therapeutics, LLC
| Record | Firm | Date |
|---|---|---|
| Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 (NCT05034874) | InterveXion Therapeutics, LLC | 2022-06-09 |
| Safety, Tolerability, and Pharmacokinetics of IXT-m200 (NCT05027451) | InterveXion Therapeutics, LLC | 2021-10-25 |
| Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose (NCT04715230) | InterveXion Therapeutics, LLC | 2021-06-30 |
| Study of Antibody for Methamphetamine Outpatient Therapy (NCT03336866) | InterveXion Therapeutics, LLC | 2018-05-03 |
Track InterveXion Therapeutics, LLC automatically
Every clearance here is in the API, with alerts when new ones post.